These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1407594)

  • 1. Intravenous immunoglobulin.
    Goldhammer Y
    Neurology; 1992 Oct; 42(10):2053-4. PubMed ID: 1407594
    [No Abstract]   [Full Text] [Related]  

  • 2. Aseptic meningitis as a complication of intravenous immunoglobulin therapy for myasthenia gravis.
    Ellis RJ; Swendson MR; Bajorek J
    Muscle Nerve; 1994 Jun; 17(6):683-4. PubMed ID: 8196714
    [No Abstract]   [Full Text] [Related]  

  • 3. [Initial manifestation of localized myasthenia gravis as a differential diagnosis to foramen jugulare syndrome].
    Schmäl F; Laubert A
    HNO; 1992 Dec; 40(12):500-1. PubMed ID: 1493973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myastenia gravis unmasked by botulinum toxin].
    Martínez-Matos JA; Gascón J; Calopa M; Montero J
    Neurologia; 2003 May; 18(4):234-5. PubMed ID: 12721872
    [No Abstract]   [Full Text] [Related]  

  • 5. Third cranial nerve palsy or pseudo 3rd nerve palsy of myasthenia gravis? A challenging diagnosis in systemic lupus erythematosus.
    Appenzeller S; Veilleux M; Clarke A
    Lupus; 2009 Aug; 18(9):836-40. PubMed ID: 19578109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary embolism associated with intravenous immunoglobulin therapy.
    Butler KS; Zeitlin DS
    Ann Pharmacother; 2003 Oct; 37(10):1530. PubMed ID: 14519037
    [No Abstract]   [Full Text] [Related]  

  • 7. Myasthenia gravis.
    Kothari MJ
    J Am Osteopath Assoc; 2004 Sep; 104(9):377-84. PubMed ID: 15452103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IV immunoglobulin in patients with myasthenia gravis: a randomized controlled trial.
    Zinman L; Ng E; Bril V
    Neurology; 2007 Mar; 68(11):837-41. PubMed ID: 17353471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the effectiveness of intravenous immunoglobulin and plasma exchange as preoperative therapy of myasthenia gravis.
    Jensen P; Bril V
    J Clin Neuromuscul Dis; 2008 Mar; 9(3):352-5. PubMed ID: 18344718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose intravenous immunoglobulin G treatment of myasthenia gravis.
    Ferrero B; Durelli L
    Neurol Sci; 2002 Apr; 23 Suppl 1():S9-24. PubMed ID: 12032583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulins and stroke.
    Ross MA; Goeken JA; Leis AA
    Neurology; 1992 Sep; 42(9):1847-8. PubMed ID: 1513488
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of myasthenia gravis exacerbation with intravenous immunoglobulin: a randomized double-blind clinical trial.
    Gajdos P; Tranchant C; Clair B; Bolgert F; Eymard B; Stojkovic T; Attarian S; Chevret S;
    Arch Neurol; 2005 Nov; 62(11):1689-93. PubMed ID: 16286541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. When do we judge IVIg for myasthenia gravis ineffective?
    Takizawa T; Suzuki S; Suzuki N
    Neurol Sci; 2015 Jul; 36(7):1295-7. PubMed ID: 25511979
    [No Abstract]   [Full Text] [Related]  

  • 14. Dyshidrotic eczema associated with the use of IVIg.
    Kotan D; Erdem T; Acar BA; Boluk A
    BMJ Case Rep; 2013 Feb; 2013():. PubMed ID: 23417935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma exchange and intravenous immunoglobulin in autoimmune myasthenia gravis.
    Gajdos P; Chevret S; Clair B; Tranchant C; Chastang C
    Ann N Y Acad Sci; 1998 May; 841():720-6. PubMed ID: 9668320
    [No Abstract]   [Full Text] [Related]  

  • 16. Extensive Postradiation Ocular and Diffuse Cranial Neuromyotonia Mimicking Myasthenia Gravis.
    Hardy TA; Lee AW; Yiannikas C; Chen CS; Reddel SW
    Neurologist; 2016 Sep; 21(5):79-82. PubMed ID: 27564076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cranial nerve injuries during multifocal neuropathies with persistent conduction blocks].
    Mari I; Chassande B; Léger JM
    Rev Neurol (Paris); 1998 Feb; 154(2):175-6. PubMed ID: 9773042
    [No Abstract]   [Full Text] [Related]  

  • 18. [Double vision as a symptom of a serious disorder].
    ter Berg JW; Samijn JP; Kuks JB
    Ned Tijdschr Geneeskd; 1998 Sep; 142(37):2025-7. PubMed ID: 9856205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose intravenous immunoglobulin for myasthenia gravis.
    Sakano T; Hamasaki T; Shimizu H; Harada Y; Ueda K
    Hiroshima J Med Sci; 1988 Mar; 37(1):7-9. PubMed ID: 3410736
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety and tolerability of intravenous immunoglobulins.
    Martin TD
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():514-20. PubMed ID: 10689502
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.